These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 7580286
1. Effect of CC chemokines on mediator release from human skin mast cells and basophils. Hartmann K, Beiglböck F, Czarnetzki BM, Zuberbier T. Int Arch Allergy Immunol; 1995 Nov; 108(3):224-30. PubMed ID: 7580286 [Abstract] [Full Text] [Related]
2. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells. Patella V, de Crescenzo G, Marino O, Spadaro G, Genovese A, Marone G. Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840 [Abstract] [Full Text] [Related]
3. Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release. Stellato C, de Crescenzo G, Patella V, Mastronardi P, Mazzarella B, Marone G. J Allergy Clin Immunol; 1996 Mar; 97(3):838-50. PubMed ID: 8613641 [Abstract] [Full Text] [Related]
4. Mechanisms of activation of human mast cells and basophils by general anesthetic drugs. Marone G, Stellato C, Mastronardi P, Mazzarella B. Ann Fr Anesth Reanim; 1993 Mar; 12(2):116-25. PubMed ID: 7690200 [Abstract] [Full Text] [Related]
5. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells. Patella V, Bouvet JP, Marone G. J Immunol; 1993 Nov 15; 151(10):5685-98. PubMed ID: 7693815 [Abstract] [Full Text] [Related]
6. Effects of basophil-priming and stimulating cytokines on histamine release from isolated human skin mast cells. Nitschke M, Sohn K, Dieckmann D, Gibbs BF, Wolff HH, Amon U. Arch Dermatol Res; 1996 Jul 15; 288(8):463-8. PubMed ID: 8844126 [Abstract] [Full Text] [Related]
7. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells. Casolaro V, Meliota S, Marino O, Patella V, de Paulis A, Guidi G, Marone G. J Pharmacol Exp Ther; 1993 Dec 15; 267(3):1375-85. PubMed ID: 7505332 [Abstract] [Full Text] [Related]
8. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. Columbo M, Horowitz EM, Botana LM, MacGlashan DW, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM. J Immunol; 1992 Jul 15; 149(2):599-608. PubMed ID: 1378071 [Abstract] [Full Text] [Related]
9. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. Stellato C, Cirillo R, de Paulis A, Casolaro V, Patella V, Mastronardi P, Mazzarella B, Marone G. Anesthesiology; 1992 Nov 15; 77(5):932-40. PubMed ID: 1280014 [Abstract] [Full Text] [Related]
10. The role of basophils in allergic disease. Knol EF, Mul FP, Lie WJ, Verhoeven AJ, Roos D. Eur Respir J Suppl; 1996 Aug 15; 22():126s-131s. PubMed ID: 8871057 [Abstract] [Full Text] [Related]
11. Heterogeneous effects of protamine on human mast cells and basophils. Patella V, Ciccarelli A, Lamparter-Schummert B, de Paulis A, Adt M, Marone G. Br J Anaesth; 1997 Jun 15; 78(6):724-30. PubMed ID: 9215027 [Abstract] [Full Text] [Related]
17. Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells. Genovese A, Patella V, De Crescenzo G, De Paulis A, Spadaro G, Marone G. Clin Exp Allergy; 1997 May 15; 27(5):559-67. PubMed ID: 9179431 [Abstract] [Full Text] [Related]
18. Differential response of human basophils and mast cells to recombinant chemokines. Füreder W, Agis H, Semper H, Keil F, Maier U, Müller MR, Czerwenka K, Höfler H, Lechner K, Valent P. Ann Hematol; 1995 May 15; 70(5):251-8. PubMed ID: 7541256 [Abstract] [Full Text] [Related]
19. RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Bischoff SC, Krieger M, Brunner T, Rot A, von Tscharner V, Baggiolini M, Dahinden CA. Eur J Immunol; 1993 Mar 15; 23(3):761-7. PubMed ID: 7680615 [Abstract] [Full Text] [Related]